Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 4/20 | 0.41 |
| ▸ | HTR1B | P28222 | 2/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | HTR1D | P28221 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28211868 | 0.98 | LTA4H (0.40) | CA4LTA4HHTR1BMTNR1AMTNR1B | |
| SCHEMBL9487129 | 0.91 | LTA4H (0.55) | LTA4HTSHRMAOA | |
| Toluene SCHEMBL27820201 | 0.91 | LMNA (0.46) | CA4LTA4HHTR1BMTNR1AMTNR1B | |
| SCHEMBL1033246 | 0.81 | HTR1B (0.42) | CA4LTA4HHTR1BMTNR1AMTNR1B | |
| SCHEMBL11579593 | 0.80 | LMNA (0.56) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Fluoride SCHEMBL27524402 | 0.79 | HTR1B (0.41) | CA4LTA4HHTR1BMTNR1AMTNR1B | |
| SCHEMBL20240300 | 0.79 | LTA4H (0.52) | LTA4HL3MBTL1 | |
| SCHEMBL11577748 | 0.78 | ACHE (0.44) | TSHRL3MBTL1 | |
| SCHEMBL11384402 | 0.78 | CA1 (0.52) | LTA4HMTNR1AMTNR1BL3MBTL1 | |
| Citric Acid SCHEMBL3233225 | 0.78 | KDM4E (0.47) | TSHRL3MBTL1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116251473-A | Nanofiltration membrane preparation method utilizing micro-monomer pre-reaction | 浙江理工大学 | 2023-06-13 | — | — | CN | claimed |
| CN-115745457-A | High-adaptability concrete superplasticizer, preparation method and application thereof | 南京博特新材料有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115725035-A | Slump-retaining concrete superplasticizer, preparation method and application thereof | 博特新材料泰州有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-113563238-A | 2-phenoxyethylamino cyclohexane sulfonamide compound and preparation method and application thereof | 沈阳农业大学 | 2021-10-29 | — | — | CN | claimed |
| US-20190119415-A1 | GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY | MERCK PATENT GMBH (DE) | 2019-04-25 | — | — | US | claimed |
| EP-2152405-B2 | GRAFT COPOLYMER FOR CATION-EXCHANGE CHROMATOGRAPHY | MERCK PATENT GMBH (DE) | 2017-04-05 | — | — | EP | claimed |
| EP-2699543-B1 | NOVEL MODULATORS OF CORTICAL DOPAMINERGIC- AND NMDA-RECEPTOR-MEDIATED GLUTAMATERGIC NEUROTRANSMISSION | INTEGRATIVE RES LAB SWEDEN AB (SE) | 2016-03-02 | — | — | EP | claimed |
| US-9120728-B2 | Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission | INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB (SE) | 2015-09-01 | — | — | US | claimed |
| US-20150238497-A1 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ACUCELA INC. | 2015-08-27 | — | — | US | claimed |
| US-20150148426-A1 | NOVEL MODULATORS OF CORTICAL DOPAMINERGIC- AND NMDA-RECEPTOR-MEDIATED GLUTAMATERGIC NEUROTRANSMISSION | INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB (SE) | 2015-05-28 | — | — | US | claimed |
| EP-0355598-B1 | BETA-PHENOXYETHYL AMINES AND THEIR USE IN THE PREPARATION OF DYES | BAYER AG (DE) | 1993-06-16 | — | — | EP | claimed |
| US-5126481-A | Cyclization, reduction, decyclization | BAYER AKTIENGESELLSCHAFT (DE) | 1992-06-30 | — | — | US | claimed |
| EP-0331943-B1 | PHENOXYETHYLAMINE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND COMPOSITION FOR EXHIBITING EXCELLENT ALPHA-1-BLOCKING ACTIVITY CONTAINING THE SAME | Hokuriku Pharmaceutical Co.,Ltd (JP) | 1992-06-17 | — | — | EP | claimed |
| EP-0429314-A2 | Phenoxyalkylamine and agricultural and horticultural bactericide | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-05-29 | — | — | EP | claimed |
| CN-1051670-A | Contain the dyeing composition for keratinous fibres of oxidation dye parent and amino indole colour former, the colouring method that uses these compositionss and noval chemical compound | OREAL (FR) | 1991-05-29 | — | — | CN | claimed |
| US-4971990-A | HYPOTENSIVE AGENTS, DYSUREA | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1990-11-20 | — | — | US | claimed |
| EP-0357310-A1 | Process for producing substituted phenoxyethylamines and intermediates | UBE INDUSTRIES, LTD. (JP) | 1990-03-07 | — | — | EP | claimed |
| EP-0355598-A2 | Beta-phenoxyethyl amines and their use in the preparation of dyes | BAYER AG (DE) | 1990-02-28 | — | — | EP | claimed |
| EP-0331943-A1 | Phenoxyethylamine derivatives, process for preparing the same, and composition for exhibiting excellent alpha-1-blocking activity containing the same | Hokuriku Pharmaceutical Co.,Ltd (JP) | 1989-09-13 | — | — | EP | claimed |
| EP-0226475-A1 | Diphenoxyethyl amine derivatives, process for their preparation and pharmaceutical compositions containing them | Albert ROLLAND S.A. Société dite (FR) | 1987-06-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238497-A1 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ALDH1A2, STARD3, TXNRD2 | CA4 4564/4885LTA4H 901/4885HTR1B 1060/4885 |
| US-20150148426-A1 | NOVEL MODULATORS OF CORTICAL DOPAMINERGIC- AND NMDA-RECEPTOR-MEDIATED GLUTAMATERGIC NEUROTRANSMISSION | GRIN3A, GRIN1, GRIN3B | CA4 4369/4885LTA4H 2685/4885HTR1B 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.